Katerina A.B. Gawronski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katerina A.B. Gawronski has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Franklin Voight
Corporal Michael Crescenz VA Medical Center, Philadelphia, USA
1 shared publication - Brandon M. Wenz
Cell and Molecular Biology Graduate Group (K.A.B.G., B.M.W.), University of Pennsylvania - Perelman School of Medicine, Philadelphia, PA
1 shared publication - Christopher D. Brown
Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
1 shared publication - Daniel James Rader
Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
1 shared publication - Evanthia E. Pashos
Department of Genetics (Y.P., E.E.P., D.J.R., K.M., B.F.V., C.D.B.), University of Pennsylvania - Perelman School of Medicine, Philadelphia, PA
1 shared publication - Kiran Musunuru
Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
1 shared publication
Latest Publications
- Open Access
- 1 June 2023
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 16 (3) , 248-257
Evaluating the Contribution of Cell Type–Specific Alternative Splicing to Variation in Lipid Levels
Background:Genome-wide association studies have identified hundreds of loci associated with lipid levels. However, the genetic mechanisms underlying most of these loci are not well-understood. Recent work indicates that changes in the abundance of alternatively spliced transcripts contribute to complex trait variation. Consequently, identifying genetic loci that associate with alternative splicing in disease-relevant cell types and determining the degree to which these loci are informative for lipid biology is of broad interest. Methods:We analyze gene splicing in 83 sample-matched induced pluripotent stem cell (iPSC) and hepatocyte-like cell lines (n=166), as well as in an independent collection of primary liver tissues (n=96) to perform discovery of splicing quantitative trait loci (sQTLs). Results:We observe that transcript splicing is highly cell type specific, and the genes that are differentially spliced between iPSCs and hepatocyte-like cells are enriched for metabolism pathway annotations. We identify 1384 hepatocyte-like cell sQTLs and 1455 iPSC sQTLs at a false discovery rate of <5% and find that sQTLs are often shared across cell types. To evaluate the contribution of sQTLs to variation in lipid levels, we conduct colocalization analysis using lipid genome-wide association data. We identify 19 lipid-associated loci that colocalize either with an hepatocyte-like cell expression quantitative trait locus or sQTL. Only 2 loci colocalize with both a sQTL and expression quantitative trait locus, indicating that sQTLs contribute information about genome-wide association studies loci that cannot be obtained by analysis of steady-state gene expression alone. Conclusions:These results provide an important foundation for future efforts that use iPSC and iPSC-derived cells to evaluate genetic mechanisms influencing both cardiovascular disease risk and complex traits in general.
- 1 June 2023
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 16 (3) , 248-257
Open AccessEvaluating the Contribution of Cell Type–Specific Alternative Splicing to Variation in Lipid Levels
Background:Genome-wide association studies have identified hundreds of loci associated with lipid levels. However, the genetic mechanisms underlying most of these loci are not well-understood. Recent work indicates that changes in the abundance of alternatively spliced transcripts contribute to complex trait variation. Consequently, identifying genetic loci that associate with alternative splicing in disease-relevant cell types and determining the degree to which these loci are informative for lipid biology is of broad interest. Methods:We analyze gene splicing in 83 sample-matched induced pluripotent stem cell (iPSC) and hepatocyte-like cell lines (n=166), as well as in an independent collection of primary liver tissues (n=96) to perform discovery of splicing quantitative trait loci (sQTLs). Results:We observe that transcript splicing is highly cell type specific, and the genes that are differentially spliced between iPSCs and hepatocyte-like cells are enriched for metabolism pathway annotations. We identify 1384 hepatocyte-like cell sQTLs and 1455 iPSC sQTLs at a false discovery rate of <5% and find that sQTLs are often shared across cell types. To evaluate the contribution of sQTLs to variation in lipid levels, we conduct colocalization analysis using lipid genome-wide association data. We identify 19 lipid-associated loci that colocalize either with an hepatocyte-like cell expression quantitative trait locus or sQTL. Only 2 loci colocalize with both a sQTL and expression quantitative trait locus, indicating that sQTLs contribute information about genome-wide association studies loci that cannot be obtained by analysis of steady-state gene expression alone. Conclusions:These results provide an important foundation for future efforts that use iPSC and iPSC-derived cells to evaluate genetic mechanisms influencing both cardiovascular disease risk and complex traits in general.